OATP1B3 substrates
DBCAT004563Pharmacologic class
A DrugBank category of 70 drugs. 65 of them are approved.
- Drugs
- Ambrisentan
- Atogepant
- Atorvastatin
- Atrasentan
- Avenciguat
- Belantamab mafodotin
- Belzutifan
- Bempedoic acid
- Brincidofovir
- Caspofungin
- Cholecystokinin
- Cholic Acid
- Conjugated estrogens
- Dabrafenib
- Datopotamab deruxtecan
- Docetaxel
- Empagliflozin
- Erythromycin
- Fexofenadine
- Firsocostat
- Fluvastatin
- Gadoxetic acid
- Glecaprevir
- Grazoprevir
- Imatinib
What you can answer from here — as of August 09, 2019
Which targets do OATP1B3 substrates share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account